NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

With an eye on cracking the regulated markets, Ahmedabad-based pharma giant Torrent Pharmaceuticals Ltd is all set to up its game for the big leap. The Rs 6,676 crore company is planning to increase its research and development (R&D) spend by over 50 per cent to about 7-8 per cent…

news

Biotechnology firm Stempeutics Research has received limited approval from the national drug regulator, DCGI , for its stem cell based product Stempeucel for treatment of Buerger's Disease. "The Drugs Controller General India has granted limited approval for manufacturing & marketing of stem cell based biological product Stempeucel for the treatment…

news

India's Sun Pharmaceutical Industries Ltd issued a weaker-than expected annual sales outlook as it grapples with increased competition in the United States as well as supply constraints, sending its shares 5 percent lower. The world fifth-largest generic drugs maker said it expects sales to climb between 8 and 10 percent…

news

Sunflower Pharmaceutical Group Co Ltd Says it plans to buy 5 million worth of equity in a Hengshui-based controlling pharmacy unit from an individual for 43 million yuan, and to boost stake in the unit to 77.1429 percent from 70 percent.   Source : reuters.com

news

Boehringer Ingelheim, a German pharmaceutical company, expects to post double-digit sales growth in the UAE on the back of new product launches this year, according to a top official. Last year the company reported annual UAE sales growth of 34 per cent and 26 per cent across the wider Mena…

news

An advisory panel to the European drug regulator recommended an approval for Gilead Sciences Inc's new drug combination to treat hepatitis C. The European Medicines Agency (EMA) said on Friday that the Committee for Medicinal Products for Human Use backed Gilead's combination of velpatasvir and sofosbuvir. (bit.ly/20JOyWA) Sofosbuvir is at…

news

Strides Shasun today said it has received tentative approval from the US health regulator for Efavirenz tablets used in treating human immunodeficiency virus ( HIV ) infection. The company has received tentative approval from the US Food and Drug Administration (USFDA) for Efavirenz tablets USP, 600 mg, Strides Shasun said…

news

Lepu Medical Technology Beijing Co Ltd Says its wholly owned subsidiary Lepu Pharmaceuticals, Inc. to acquire Henan-based pharmaceutical company for 52.2 million yuan.   Source : reuters.com

news

Glenmark Pharmaceuticals Limited, the research-led global integrated pharmaceutical company, launched what the company touted as India's first Digital Dose Inhaler for asthma and pulmonary disease patients. The inhaler, branded as Digihaler, provides accurate digital dose counter along with low dose warning indicator to enable asthma and chronic obstructive pulmonary disease…

news

AstraZeneca said on Friday U.S. regulators would not approve its new drug for high potassium levels at present due to a manufacturing issue, dealing a blow to a product acquired when it bought ZS Pharma for $2.7 billion last year. The British drugmaker said the Food and Drug Administration (FDA)…